| In a monogamous heterosexual relationship of more than 12 months, there is no indication for the use of barrier contraceptives to reduce the risk of hepatitis C virus (HCV) transmission in a serodiscordant-infected couple (Ackerman et al., 1998). | Conditional |
|---|---|
| ⊕⊕○○ | |
| All patients with an active or chronic HCV-infection must be reviewed by an infectious disease/liver specialist before initiating any medically assisted reproduction treatment (MAR). | GPP |
| Commencing with MAR treatments in patients positive for HCV should be a joint decision between the patient, their partner, the fertility doctor and the infectious disease/liver specialist. | Strong |
| ⊕○○○ | |
| In the case of the female testing positive for HCV, the possibility of viral vertical transmission should be discussed prior to MAR treatment. | GPP |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.